Quoin Pharmaceuticals Ltd ADR (QNRX)

$7.20 -0.11 (-1.44%)
Market Cap 4.24M
Revenue (ttm) 0.00
Net Income (ttm) -8.96M
EPS (ttm) N/A
PE Ratio 0.00
Forward PE N/A
Profit Margin 0.00%
Debt to Equity Ratio 0.00
Volume 8,700
Avg Vol 53,004
Day's Range N/A - N/A
Shares Out 588,000.00
Stochastic %K 47%
Beta 1.66
Analysts Strong Sell
Price Target $40.67

Company Profile

Quoin Pharmaceuticals, Ltd., a late stage specialty pharmaceutical company, focuses on the development and commercialization of therapeutic products for rare and orphan diseases in the United States. The company's lead product is QRX003, a topical lotion to treat Netherton Syndrome (NS). It also developing QRX004 for the treatment of recessive dystrophic epidermolysis bullosa; QRX007 to treat Netherton Syndrome; and QRX008 for the treatment of scleroderma. It has a research agreement with Queens...

Industry: Biotechnology
Sector: Healthcare
Phone: 703 980 4182
Address:
42127 Pleasant Forest Court, Ashburn, United States
WhoDoneIt69
WhoDoneIt69 Oct. 3 at 4:28 PM
$QNRX I’m curious how many zeros would follow the decimal if this scam stock reflected its true value .. could probably figure it out.. but not knowing makes it so much more fun when I see people still bullish here 😂😂 SEC should fix the floor here, if there ever was one!
0 · Reply
HouseOfTheDragons
HouseOfTheDragons Oct. 3 at 2:58 AM
Looks like volume & momentum could be shifting in to ASTC! Tiny float getting a lot of attention and could explode upwards on volume. Watchers on ASTC are growing very fast and it could be the potential top runner for this week! Starting its 300% run - keep it on watch! Also watching for breakout: $KITT $ATXG $MBOT $QNRX nd
0 · Reply
MoonCowBoy
MoonCowBoy Oct. 3 at 1:11 AM
$QNRX $VEEE $TGL $SPPL >
0 · Reply
MexaTraders
MexaTraders Oct. 2 at 8:18 PM
Ticker ASTC is starting to move. 6.40$ break could send ASTC into a potential HALT-up or squeeze. It is breaking out and starting its 300% run now! Can we see a massive run of ASTC into close? Micro float Squeezer is making a move! $ILLR $KITT $QNRX $BDRX )(
0 · Reply
1Spartantrade1
1Spartantrade1 Oct. 2 at 6:53 PM
Massive merger news 3 days ago on NITO! NITO has a low share count like TTNP (BTTC) does. TTNP ran 400% today. Can NITO also run 400%? Make sure to take profits. Lets see if NITO halts up today when people realize. $AMRN $WBUY $TPST $QNRX 🔥
0 · Reply
BullsEyePick
BullsEyePick Oct. 2 at 4:54 AM
Looking for the next Monster runner?🚨🚨 Make sure you have ticker IVDA on ur watch. IVDA is Truly a gem of a ticker, known for big runs and perfect for a market like this where this can go on a massive rally of 400-500%+. IVDA has everything going for it, news/approved crypto treasury/Ai /Drone and most important of all it's a low float ticker. Be early bulls, because it will take off fast!! $QNRX $MTEX $ARBB $ANGH
0 · Reply
The_Gambl3r
The_Gambl3r Sep. 30 at 1:42 PM
$QNRX
0 · Reply
LegendaryCharts
LegendaryCharts Sep. 28 at 10:22 PM
$PAVS Top of the watchlist for a pre-market squeeze up - massive breakout friday! Low float mania going crazy next $QNRX Due for some news $PRZO Likes to pop during wars $GLXG recent spliter
0 · Reply
CarolinesCurrency
CarolinesCurrency Sep. 27 at 12:03 AM
IVDA is one of the only low-float stocks tied to AI surveillance, autonomous drones, and threat detection. If you think robotics, safety, and government tech will scale, you’re looking at one of the earliest and cheapest ways to play it. Zero hype. Max upside. $EYEN $PALI $LGVN $QNRX $NGM
0 · Reply
TradingBeasts
TradingBeasts Sep. 24 at 5:40 PM
$QNRX added 500 more
0 · Reply
Latest News on QNRX
Quoin Pharmaceuticals Releases Fifth NETHERTON NOW Video Featuring Writers and Influencers Allie and Kaleigh Fasanella, Twin Sisters Living with Netherton Syndrome

Sep 9, 2025, 8:30 AM EDT - 25 days ago

Quoin Pharmaceuticals Releases Fifth NETHERTON NOW Video Featuring Writers and Influencers Allie and Kaleigh Fasanella, Twin Sisters Living with Netherton Syndrome

Quoin Pharmaceuticals Appoints New Chief Financial Officer to Support Commercialization Strategy

Aug 18, 2025, 8:30 AM EDT - 6 weeks ago

Quoin Pharmaceuticals Appoints New Chief Financial Officer to Support Commercialization Strategy

Quoin Pharmaceuticals Releases Fourth Episode in NETHERTON NOW Video Series Featuring International Patient Advocate Mandy Aldwin-Easton

Aug 12, 2025, 8:30 AM EDT - 7 weeks ago

Quoin Pharmaceuticals Releases Fourth Episode in NETHERTON NOW Video Series Featuring International Patient Advocate Mandy Aldwin-Easton

Quoin Pharmaceuticals Provides Product Portfolio Update

Jul 29, 2025, 8:30 AM EDT - 2 months ago

Quoin Pharmaceuticals Provides Product Portfolio Update

Quoin Pharmaceuticals Announces European Medicines Agency (EMA) Grants Orphan Drug Designation for QRX003 for the Treatment of Netherton Syndrome

May 20, 2025, 7:30 AM EDT - 4 months ago

Quoin Pharmaceuticals Announces European Medicines Agency (EMA) Grants Orphan Drug Designation for QRX003 for the Treatment of Netherton Syndrome

Quoin Pharmaceuticals Announces Initial Positive Clinical Data for QRX003 from Pediatric Peeling Skin Syndrome Study

May 14, 2025, 7:30 AM EDT - 5 months ago

Quoin Pharmaceuticals Announces Initial Positive Clinical Data for QRX003 from Pediatric Peeling Skin Syndrome Study

Quoin Pharmaceuticals Regains Compliance with Nasdaq Minimum Bid Price Rule

Apr 30, 2025, 7:30 AM EDT - 5 months ago

Quoin Pharmaceuticals Regains Compliance with Nasdaq Minimum Bid Price Rule

Quoin Pharmaceuticals Releases Second Episode of its “Living with Netherton” Series, as part of its ongoing NETHERTON NOW awareness campaign

Apr 10, 2025, 7:30 AM EDT - 6 months ago

Quoin Pharmaceuticals Releases Second Episode of its “Living with Netherton” Series, as part of its ongoing NETHERTON NOW awareness campaign

Quoin Pharmaceuticals Announces Additional Positive ‘Whole Body' Clinical Data from Ongoing Pediatric Netherton Syndrome Study and Approval to Initiate Testing of a Second Pediatric Patient

Apr 2, 2025, 7:30 AM EDT - 6 months ago

Quoin Pharmaceuticals Announces Additional Positive ‘Whole Body' Clinical Data from Ongoing Pediatric Netherton Syndrome Study and Approval to Initiate Testing of a Second Pediatric Patient

Sphere Bio launches Cyto-Cellect Human IgG Kappa and Viability Assay Kit for efficient single-cell selection

Mar 31, 2025, 4:18 AM EDT - 6 months ago

Sphere Bio launches Cyto-Cellect Human IgG Kappa and Viability Assay Kit for efficient single-cell selection

Quoin Pharmaceuticals Files U.S. Patent Application for Novel Topical Formulations to Treat Netherton Syndrome and Other Skin Diseases

Mar 25, 2025, 7:30 AM EDT - 6 months ago

Quoin Pharmaceuticals Files U.S. Patent Application for Novel Topical Formulations to Treat Netherton Syndrome and Other Skin Diseases

Quoin Pharmaceuticals Provides Corporate Update and Reports Fourth Quarter and Full-Year 2024 Financial Results

Mar 13, 2025, 7:30 AM EDT - 7 months ago

Quoin Pharmaceuticals Provides Corporate Update and Reports Fourth Quarter and Full-Year 2024 Financial Results

Quoin Pharmaceuticals Files U.S. and International Patent Applications for Novel Topical Rapamycin Formulations to Treat Rare Disease Indications

Mar 4, 2025, 7:30 AM EST - 7 months ago

Quoin Pharmaceuticals Files U.S. and International Patent Applications for Novel Topical Rapamycin Formulations to Treat Rare Disease Indications

Quoin Pharmaceuticals Announces Highly Positive ‘Whole Body' Clinical Data from Ongoing Pediatric Netherton Syndrome Study

Feb 27, 2025, 7:30 AM EST - 7 months ago

Quoin Pharmaceuticals Announces Highly Positive ‘Whole Body' Clinical Data from Ongoing Pediatric Netherton Syndrome Study

Quoin Pharmaceuticals Launches First Episode of “NETHERTON NOW” Video Series to Raise Awareness for Netherton Syndrome

Feb 25, 2025, 7:30 AM EST - 7 months ago

Quoin Pharmaceuticals Launches First Episode of “NETHERTON NOW” Video Series to Raise Awareness for Netherton Syndrome

Quoin Pharmaceuticals Launches ‘NETHERTON NOW' Campaign to Raise Awareness of Netherton Syndrome, a Rare Genetic Disease with No Approved Treatment or Cure

Feb 4, 2025, 7:30 AM EST - 8 months ago

Quoin Pharmaceuticals Launches ‘NETHERTON NOW' Campaign to Raise Awareness of Netherton Syndrome, a Rare Genetic Disease with No Approved Treatment or Cure

Quoin Pharmaceuticals Announces Further Clinical Evidence of QRX003 Effectiveness in Netherton Syndrome

Jan 23, 2025, 8:30 AM EST - 9 months ago

Quoin Pharmaceuticals Announces Further Clinical Evidence of QRX003 Effectiveness in Netherton Syndrome

Skinvisible Reports Licensee Success in Netherton Syndrome Clinical Studies

Jan 23, 2025, 5:30 AM EST - 9 months ago

Skinvisible Reports Licensee Success in Netherton Syndrome Clinical Studies

Quoin Pharmaceuticals Announces Additional Positive Interim Data from Ongoing Open-Label Netherton Syndrome Clinical Study

Jan 6, 2025, 8:30 AM EST - 9 months ago

Quoin Pharmaceuticals Announces Additional Positive Interim Data from Ongoing Open-Label Netherton Syndrome Clinical Study

Quoin Pharmaceuticals Announces Pricing of $6.8 Million Public Offering

Dec 20, 2024, 9:20 AM EST - 10 months ago

Quoin Pharmaceuticals Announces Pricing of $6.8 Million Public Offering

Quoin Pharmaceuticals Announces FDA Clearance to Initiate New QRX003 Netherton Syndrome Clinical Study

Dec 19, 2024, 8:00 AM EST - 10 months ago

Quoin Pharmaceuticals Announces FDA Clearance to Initiate New QRX003 Netherton Syndrome Clinical Study

Quoin Pharmaceuticals Announces Positive Interim Data from Two Ongoing Netherton Syndrome Clinical Studies

Dec 18, 2024, 8:18 AM EST - 10 months ago

Quoin Pharmaceuticals Announces Positive Interim Data from Two Ongoing Netherton Syndrome Clinical Studies

Quoin Pharmaceuticals to Announce Third Quarter 2024 Financial Results on Thursday, November 7, 2024

Oct 31, 2024, 4:05 PM EDT - 1 year ago

Quoin Pharmaceuticals to Announce Third Quarter 2024 Financial Results on Thursday, November 7, 2024

Quoin Pharmaceuticals Announces Insider Share Purchases by Co-Founders CEO and COO

Sep 9, 2024, 8:30 AM EDT - 1 year ago

Quoin Pharmaceuticals Announces Insider Share Purchases by Co-Founders CEO and COO

Quoin Pharmaceuticals Provides Corporate Update and Announces Second Quarter 2024 Financial Results

Aug 8, 2024, 8:30 AM EDT - 1 year ago

Quoin Pharmaceuticals Provides Corporate Update and Announces Second Quarter 2024 Financial Results

Quoin Pharmaceuticals to Initiate Clinical Study for Peeling Skin Syndrome

Aug 6, 2024, 5:00 AM EDT - 1 year ago

Quoin Pharmaceuticals to Initiate Clinical Study for Peeling Skin Syndrome

Quoin Pharmaceuticals to Announce Second Quarter 2024 Financial Results on Thursday, August 8, 2024

Aug 1, 2024, 4:10 PM EDT - 1 year ago

Quoin Pharmaceuticals to Announce Second Quarter 2024 Financial Results on Thursday, August 8, 2024

Quoin Pharmaceuticals to Sponsor the Foundation for Ichthyosis & Related Skin Types (FIRST) 2024 National Conference

Jun 25, 2024, 4:05 PM EDT - 1 year ago

Quoin Pharmaceuticals to Sponsor the Foundation for Ichthyosis & Related Skin Types (FIRST) 2024 National Conference

Quoin Pharmaceuticals Announces Signing of Research Agreement with University College Cork (UCC), Ireland

Jun 12, 2024, 8:00 AM EDT - 1 year ago

Quoin Pharmaceuticals Announces Signing of Research Agreement with University College Cork (UCC), Ireland

Quoin Pharmaceuticals Provides Corporate Update and Announces First Quarter 2024 Financial Results

May 9, 2024, 8:30 AM EDT - 1 year ago

Quoin Pharmaceuticals Provides Corporate Update and Announces First Quarter 2024 Financial Results

Quoin Pharmaceuticals to Announce First Quarter 2024 Financial Results on May 9, 2024

May 2, 2024, 4:10 PM EDT - 1 year ago

Quoin Pharmaceuticals to Announce First Quarter 2024 Financial Results on May 9, 2024

Quoin Pharmaceuticals, Ltd. (QNRX) Q4 2023 Earnings Call Transcript

Mar 14, 2024, 12:57 PM EDT - 1 year ago

Quoin Pharmaceuticals, Ltd. (QNRX) Q4 2023 Earnings Call Transcript

Quoin Pharmaceuticals Provides Corporate Update and Announces Fourth Quarter and 2023 Financial Results

Mar 13, 2024, 4:05 PM EDT - 1 year ago

Quoin Pharmaceuticals Provides Corporate Update and Announces Fourth Quarter and 2023 Financial Results

Quoin Pharmaceuticals Announces Fourth Quarter and 2023 Financial Results and Corporate Update Conference Call to be held on Thursday March 14th at 8:30 am ET

Mar 7, 2024, 4:05 PM EST - 1 year ago

Quoin Pharmaceuticals Announces Fourth Quarter and 2023 Financial Results and Corporate Update Conference Call to be held on Thursday March 14th at 8:30 am ET

Skinvisible Announces Significant Progress in Licensee's Clinical Trials for Invisicare Formulation Targeting Nethertons Syndrome

Feb 14, 2024, 9:00 AM EST - 1 year ago

Skinvisible Announces Significant Progress in Licensee's Clinical Trials for Invisicare Formulation Targeting Nethertons Syndrome

Quoin Pharmaceuticals Announces FDA Clearance of Clinical Optimization Plan for QRX003 for Netherton Syndrome

Dec 13, 2023, 8:30 AM EST - 1 year ago

Quoin Pharmaceuticals Announces FDA Clearance of Clinical Optimization Plan for QRX003 for Netherton Syndrome

Quoin Pharmaceuticals, Ltd. (QNRX) Q3 2023 Earnings Call Transcript

Nov 9, 2023, 10:51 AM EST - 2 years ago

Quoin Pharmaceuticals, Ltd. (QNRX) Q3 2023 Earnings Call Transcript

Quoin Pharmaceuticals Provides Corporate Update and Announces Third Quarter 2023 Financial Results

Nov 8, 2023, 5:46 PM EST - 2 years ago

Quoin Pharmaceuticals Provides Corporate Update and Announces Third Quarter 2023 Financial Results

Quoin Pharmaceuticals Announces Third Quarter 2023 Financial Results and Corporate Update Conference Call to be held on Thursday November 9th at 8:30 am ET

Nov 3, 2023, 8:41 AM EDT - 2 years ago

Quoin Pharmaceuticals Announces Third Quarter 2023 Financial Results and Corporate Update Conference Call to be held on Thursday November 9th at 8:30 am ET

REPEAT -- Quoin Pharmaceuticals Announces Additional Positive Clinical Data from Open-Label, Single-Arm Clinical Trial in Netherton Syndrome

Oct 24, 2023, 9:32 AM EDT - 2 years ago

REPEAT -- Quoin Pharmaceuticals Announces Additional Positive Clinical Data from Open-Label, Single-Arm Clinical Trial in Netherton Syndrome

Quoin Pharmaceuticals Announces Additional Positive Clinical Data from Open-Label, Single-Arm Clinical Trial in Netherton Syndrome

Oct 24, 2023, 8:28 AM EDT - 2 years ago

Quoin Pharmaceuticals Announces Additional Positive Clinical Data from Open-Label, Single-Arm Clinical Trial in Netherton Syndrome

Quoin Pharmaceuticals, Ltd. (QNRX) Q2 2023 Earnings Call Transcript

Aug 7, 2023, 1:24 AM EDT - 2 years ago

Quoin Pharmaceuticals, Ltd. (QNRX) Q2 2023 Earnings Call Transcript

Quoin Pharmaceuticals Provides Corporate Update and Announces Second Quarter 2023 Financial Results

Aug 2, 2023, 4:45 PM EDT - 2 years ago

Quoin Pharmaceuticals Provides Corporate Update and Announces Second Quarter 2023 Financial Results

Quoin Pharmaceuticals Announces 50% Enrollment in Open Label Netherton Syndrome Clinical Trial

May 24, 2023, 8:15 AM EDT - 2 years ago

Quoin Pharmaceuticals Announces 50% Enrollment in Open Label Netherton Syndrome Clinical Trial

Quoin Pharmaceuticals, Ltd. (QNRX) Q1 2023 Earnings Call Transcript

May 12, 2023, 4:43 PM EDT - 2 years ago

Quoin Pharmaceuticals, Ltd. (QNRX) Q1 2023 Earnings Call Transcript

Quoin Pharmaceuticals Provides Corporate Update and Announces First Quarter 2023 Financial Results

May 8, 2023, 5:00 PM EDT - 2 years ago

Quoin Pharmaceuticals Provides Corporate Update and Announces First Quarter 2023 Financial Results

Quoin Pharmaceuticals Announces First Quarter 2023 Financial Results and Corporate Update Conference Call to Be Held on Tuesday, May 9, 2023 at 8:30 am ET

May 2, 2023, 8:30 AM EDT - 2 years ago

Quoin Pharmaceuticals Announces First Quarter 2023 Financial Results and Corporate Update Conference Call to Be Held on Tuesday, May 9, 2023 at 8:30 am ET

Quoin Pharmaceuticals Doses First Patient in Open Label Netherton Syndrome Clinical Trial

Mar 21, 2023, 8:30 AM EDT - 2 years ago

Quoin Pharmaceuticals Doses First Patient in Open Label Netherton Syndrome Clinical Trial

Quoin Pharmaceuticals, Ltd. (QNRX) Q4 2022 Earnings Call Transcript

Mar 9, 2023, 2:27 PM EST - 2 years ago

Quoin Pharmaceuticals, Ltd. (QNRX) Q4 2022 Earnings Call Transcript

Quoin Pharmaceuticals Provides Corporate Update and Announces Fourth Quarter and Full Year 2022 Financial Results

Mar 8, 2023, 5:08 PM EST - 2 years ago

Quoin Pharmaceuticals Provides Corporate Update and Announces Fourth Quarter and Full Year 2022 Financial Results

WhoDoneIt69
WhoDoneIt69 Oct. 3 at 4:28 PM
$QNRX I’m curious how many zeros would follow the decimal if this scam stock reflected its true value .. could probably figure it out.. but not knowing makes it so much more fun when I see people still bullish here 😂😂 SEC should fix the floor here, if there ever was one!
0 · Reply
HouseOfTheDragons
HouseOfTheDragons Oct. 3 at 2:58 AM
Looks like volume & momentum could be shifting in to ASTC! Tiny float getting a lot of attention and could explode upwards on volume. Watchers on ASTC are growing very fast and it could be the potential top runner for this week! Starting its 300% run - keep it on watch! Also watching for breakout: $KITT $ATXG $MBOT $QNRX nd
0 · Reply
MoonCowBoy
MoonCowBoy Oct. 3 at 1:11 AM
$QNRX $VEEE $TGL $SPPL >
0 · Reply
MexaTraders
MexaTraders Oct. 2 at 8:18 PM
Ticker ASTC is starting to move. 6.40$ break could send ASTC into a potential HALT-up or squeeze. It is breaking out and starting its 300% run now! Can we see a massive run of ASTC into close? Micro float Squeezer is making a move! $ILLR $KITT $QNRX $BDRX )(
0 · Reply
1Spartantrade1
1Spartantrade1 Oct. 2 at 6:53 PM
Massive merger news 3 days ago on NITO! NITO has a low share count like TTNP (BTTC) does. TTNP ran 400% today. Can NITO also run 400%? Make sure to take profits. Lets see if NITO halts up today when people realize. $AMRN $WBUY $TPST $QNRX 🔥
0 · Reply
BullsEyePick
BullsEyePick Oct. 2 at 4:54 AM
Looking for the next Monster runner?🚨🚨 Make sure you have ticker IVDA on ur watch. IVDA is Truly a gem of a ticker, known for big runs and perfect for a market like this where this can go on a massive rally of 400-500%+. IVDA has everything going for it, news/approved crypto treasury/Ai /Drone and most important of all it's a low float ticker. Be early bulls, because it will take off fast!! $QNRX $MTEX $ARBB $ANGH
0 · Reply
The_Gambl3r
The_Gambl3r Sep. 30 at 1:42 PM
$QNRX
0 · Reply
LegendaryCharts
LegendaryCharts Sep. 28 at 10:22 PM
$PAVS Top of the watchlist for a pre-market squeeze up - massive breakout friday! Low float mania going crazy next $QNRX Due for some news $PRZO Likes to pop during wars $GLXG recent spliter
0 · Reply
CarolinesCurrency
CarolinesCurrency Sep. 27 at 12:03 AM
IVDA is one of the only low-float stocks tied to AI surveillance, autonomous drones, and threat detection. If you think robotics, safety, and government tech will scale, you’re looking at one of the earliest and cheapest ways to play it. Zero hype. Max upside. $EYEN $PALI $LGVN $QNRX $NGM
0 · Reply
TradingBeasts
TradingBeasts Sep. 24 at 5:40 PM
$QNRX added 500 more
0 · Reply
TradingBeasts
TradingBeasts Sep. 24 at 5:36 PM
$QNRX should run soon
0 · Reply
bobbydoles
bobbydoles Sep. 24 at 2:05 PM
$HUIZ up next $ATCH $LAC $QNRX
0 · Reply
PheonixRising
PheonixRising Sep. 24 at 11:30 AM
$QNRX 👀
0 · Reply
JamieBlackwell
JamieBlackwell Sep. 23 at 6:14 PM
$QNRX NXXT strong close yesterday sets up gap and go potential monitor first fifteen for ORB confirmation
0 · Reply
PriceSniper84
PriceSniper84 Sep. 22 at 5:40 PM
$QNRX NXXT reclaim over VWAP was textbook perfect retest and go pattern staying long for trend ride
0 · Reply
TraderJay85
TraderJay85 Sep. 22 at 12:01 PM
$LASE $SWIN $ANGX $QNRX $ZONE Told ya that $LASE was setting up again. Cant get in any lower. went to 5.28 this time. easy 25% gains this morning. These other ones will go soon. NO EMAILS NO DISCORDS JUST FREE IDEAS TO EVERYONE. HIT THE FOLLOW AND LETS MAKE MONEY TOGETHER
1 · Reply
TraderJay85
TraderJay85 Sep. 21 at 11:49 PM
$LASE $SWIN $ANGX $QNRX $ZONE Tagged my favorite set ups^^ Some new tickers i found that are ready. also put what im willing to risk in case it goes south. Always have a plan. HODL is not a trading strategy. We had an insane month so far. lets keep it going this week. be smart be patient. REMEMBER NO EMAILS NO DISCORDS JUST FREE IDEAS TO EVERYONE. LETS MAKE MONEY TOGETHER.
2 · Reply
StockHounding
StockHounding Sep. 21 at 3:31 PM
$QNRX this on has been popular for years Congrats bulls $PAVS will take everyone by surprise this upcoming week. It really is set up nicely and nearly zero borrow $SINT and RMCO are both extremely bullish.
0 · Reply
AtlasFrontier
AtlasFrontier Sep. 20 at 11:10 PM
Ticker BOXL getting a lot of buzz, Can this be the next parabolic runner for next week. I would not be surprised if BOXL has one of those big squeeze rally of 400-500% BOXL fits the theme of what market is sending right now. Low float gems with News. this 1.8M floater has that potential!! Good watches. $PSQH $SQFT $MTEX $QNRX
0 · Reply
BullsEyePick
BullsEyePick Sep. 20 at 8:03 PM
Ticker BOXL has the same ingredients as past parabolic runners — but it’s still cheap.💎 Top watch next week. ✅ Zero borrow ✅ No dilution ✅ $30+ valuation case ✅ Next leg could be wild. Also watching: $VEEE $QNRX $OXBR $DLPN
0 · Reply
daytrader11345
daytrader11345 Sep. 19 at 2:07 PM
$QNRX loading
0 · Reply
TraderJay85
TraderJay85 Sep. 18 at 9:37 PM
All these are setting up and should be on close watch. $MTVA $ANGX $NAOV $GORV $QNRX
1 · Reply